NM_001267550.2:c.70162C>T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001267550.2(TTN):c.70162C>T(p.Arg23388*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000434 in 1,611,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R23388R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.70162C>T | p.Arg23388* | stop_gained | Exon 326 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.70162C>T | p.Arg23388* | stop_gained | Exon 326 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152024Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459106Hom.: 0 Cov.: 36 AF XY: 0.00000551 AC XY: 4AN XY: 725338 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74234 show subpopulations
ClinVar
Submissions by phenotype
not specified Pathogenic:1
- -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg23388*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (rs781540455, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with atrial fibrillation, dilated cardiomyopathy, and/or left ventricular non-compaction cardiomyopathy (PMID: 29029073, 30535219, 33190517, 34495297, 36264615; internal data). ClinVar contains an entry for this variant (Variation ID: 202402). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). For these reasons, this variant has been classified as Pathogenic. -
Dilated cardiomyopathy 1G Pathogenic:1
- -
not provided Pathogenic:1
Identified in patients with left ventricular noncompaction (LVNC), dilated cardiomyopathy (DCM), and early-onset atrial fibrillation in the published literature (PMID: 29029073, 30535219, 33190517, 34495297); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Located in the A-band region of TTN in which the majority of loss of function variants have been associated with autosomal dominant titinopathies (PMID: 22335739); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30535219, 33190517, 36264615, 31691645, 34495297, 22335739, 29029073) -
Cardiovascular phenotype Pathogenic:1
The p.R14323* pathogenic mutation (also known as c.42967C>T), located in coding exon 153 of the TTN gene, results from a C to T substitution at nucleotide position 42967. This changes the amino acid from an arginine to a stop codon within coding exon 153. This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant (also referred to as NM_001267550:c.70162C>T, p.R23388X) was reported in individual(s) with features consistent with dilated cardiomyopathy, left ventricular noncompaction, and early onset atrial fibrillation (Sedaghat-Hamedani F et al. Eur Heart J, 2017 Dec;38:3449-3460; Choi SH et al. JAMA, 2018 12;320:2354-2364; Brown EE et al. Circ Genom Precis Med. 2020 Dec;13(6):e003082; Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (DCM) (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at